Eleven Therapeutics is a startup, 1 tracked investor.
Eleven Therapeutics is a startup. Brouky records 1 investor associated with the company.
Eleven Therapeutics develops next-generation RNA therapeutics and an AI-driven design platform (xRNA) that applies massively-parallel combinatorial chemistry, sequencing, and big-data methods to map RNA chemical space and optimize structure-activity relationships for safety, efficiency, and duration of effect.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.